(1S,3R,5R)-PIM447 dihydrochloride
|
S659341-1mg
|
≥98% |
N/A |
1mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
Sofosbuvir impurity B
|
S659323-5mg
|
|
N/A |
5mg
|
¥ 35000.9
|
期货,请咨询 |
阿拉丁 |
Sofosbuvir impurity B
|
S659323-1mg
|
|
N/A |
1mg
|
¥ 15000.9
|
期货,请咨询 |
阿拉丁 |
Spadin TFA
|
S659299-5mg
|
≥99% |
N/A |
5mg
|
¥ 5400.9
|
期货,请咨询 |
阿拉丁 |
Spadin TFA
|
S659299-1mg
|
≥99% |
N/A |
1mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
Sulfaguanidine-13C6
|
S659284-1mg
|
≥99% |
N/A |
1mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
STING agonist-7
|
S659260-5mg
|
≥97% |
N/A |
5mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
STING agonist-7
|
S659260-50mg
|
≥97% |
N/A |
50mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
STING agonist-7
|
S659260-25mg
|
≥97% |
N/A |
25mg
|
¥ 9500.9
|
期货,请咨询 |
阿拉丁 |
STING agonist-7
|
S659260-10mg
|
≥97% |
N/A |
10mg
|
¥ 4800.9
|
期货,请咨询 |
阿拉丁 |
(2S,3R)-Voruciclib hydrochloride
|
S659252-5mg
|
≥98% |
N/A |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
(2S,3R)-Voruciclib hydrochloride
|
S659252-50mg
|
≥98% |
N/A |
50mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
(2S,3R)-Voruciclib hydrochloride
|
S659252-10mg
|
≥98% |
N/A |
10mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
(2S,3R)-Voruciclib hydrochloride
|
S659252-100mg
|
≥98% |
N/A |
100mg
|
¥ 22500.9
|
期货,请咨询 |
阿拉丁 |
SW2_152F
|
S659228-5mg
|
≥99% |
N/A |
5mg
|
¥ 13000.9
|
期货,请咨询 |
阿拉丁 |
SW2_152F
|
S659228-1mg
|
≥99% |
N/A |
1mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
SiRNA Negative Control
|
S659212-5mg
|
≥96% |
N/A |
5mg
|
¥ 5300.9
|
期货,请咨询 |
阿拉丁 |
SiRNA Negative Control
|
S659212-1mg
|
≥96% |
N/A |
1mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |
SiRNA Negative Control
|
S659212-10mg
|
≥96% |
N/A |
10mg
|
¥ 8400.9
|
期货,请咨询 |
阿拉丁 |
sn-Glycerol 3-phosphate lithium
|
S659209-5mg
|
≥98% |
N/A |
5mg
|
¥ 1500.9
|
期货,请咨询 |
阿拉丁 |
sn-Glycerol 3-phosphate lithium
|
S659209-25mg
|
≥98% |
N/A |
25mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
sn-Glycerol 3-phosphate lithium
|
S659209-10mg
|
≥98% |
N/A |
10mg
|
¥ 2600.9
|
期货,请咨询 |
阿拉丁 |
Selepressin acetate
|
S659198-5mg
|
Moligand™, ≥98% |
876296-47-8 |
5mg
|
¥ 7199.9
|
期货,请咨询 |
阿拉丁 |
Selepressin acetate
|
S659198-1mg
|
Moligand™, ≥98% |
876296-47-8 |
1mg
|
¥ 3099.9
|
期货,请咨询 |
阿拉丁 |